Recent studies demonstrated that LBX2-AS1 is critically upregulated in most CRC tissues compared with adjacent non-tumor tissues, and LBX2-AS1 expression levels gradually increase in parallel with advanced CRC tumor stages. The gene discussed is LBX2; the disease is colorectal carcinoma.